Cargando…

Development and validation of an instrument (CSII – Brazil) to assess users’ conceptual and procedural knowledge of continuous subcutaneous infusion systems

OBJECTIVE: To develop, adapt and validate an instrument named “CSII – Brazil” to assess users’ conceptual and procedural knowledge of continuous subcutaneous insulin infusion systems. MATERIALS AND METHODS: Methodological and exploratory study developed in three stages: a) instrument development; b)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amaral, Camilla Magalhães de Oliveira, Borges, Carla Ferraz de Oliveira, Pagano, Adriana Silvina, Soares, Aleida Nazareth, Mourão, Gabriela Franco, Reis, Janice Sepúlveda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528706/ https://www.ncbi.nlm.nih.gov/pubmed/33320450 http://dx.doi.org/10.20945/2359-3997000000314

Ejemplares similares

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Brazilian version of “The Insulin Delivery System Rating Questionnaire”: translation, cross-cultural adaptation and validation
por: Coelho, Raquel Cristina Lopes Assis, et al.
Publicado: (2020)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation
por: Petkova, Elina, et al.
Publicado: (2013)

Type 1 diabetes mellitus: can coaching improve health outcomes?
por: Magalhães, Thais Pereira Costa, et al.
Publicado: (2018)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
por: Scott, Emma S, et al.
Publicado: (2019)

Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials
por: Li, Hui, et al.
Publicado: (2022)

Experiences and decision making during paediatric transitions to continuous sub-cutaneous insulin infusion (CSII): A mixed method study
por: Altmann, Erika, et al.
Publicado: (2018)

CSII treatment as an option in high-risk pregnant patients with type 1 diabetes
por: Breder, Íkaro Soares Santos, et al.
Publicado: (2015)

Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy
por: Scott, E S, et al.
Publicado: (2017)

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019)

On the Subcutaneous Injection of Blood, Infusion (Subcutaneous) and Intravenous Transfusion
por: Oehler,, et al.
Publicado: (1888)

Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2Goal(SM) concept
por: Cohen, O., et al.
Publicado: (2016)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis
por: William, Jimmy, et al.
Publicado: (2022)

Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study
por: Yao, Ming-yan, et al.
Publicado: (2019)

Instrumental support: A conceptual analysis
por: Schultz, Beth E., et al.
Publicado: (2022)

Affordances of musical instruments: Conceptual consideration
por: Tullberg, Markus
Publicado: (2022)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

LHC Beam Instrumentation Conceptual Design Report
por: Bosser, Jacques, et al.
Publicado: (2000)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Utility of an Increment in the Basal Rate during Mealtime in Place of Pre-meal Boluses for Preschool-aged Children with Type 1 Diabetes Using CSII
por: Suzuki, Junichi, et al.
Publicado: (2009)

Domestic violence on children: development and validation of an instrument to evaluate knowledge of health professionals
por: Oliveira, Lanuza Borges, et al.
Publicado: (2016)

Development and validation of an instrument to assess Brazilian healthcare professional providers’ knowledge on sickle cell disease
por: Diniz, Katy Karoline Santos, et al.
Publicado: (2019)

Illiteracy and diabetes: educational program for people with type 2 diabetes in the public health system
por: de Oliveira, Sheila Mara Silva, et al.
Publicado: (2015)

Comparison of generic and specific instruments to assess the quality of life in patients with melasma
por: Meneguin, Silmara, et al.
Publicado: (2022)

Network as transconcept: elements for a conceptual demarcation in the field of public health
por: Amaral, Carlos Eduardo Menezes, et al.
Publicado: (2016)

Conceptual design of the post-PETS instrumentation line for CLIC
por: Olvegård, Maja, et al.
Publicado: (2013)

Conceptualizing a Product with the Food-Related Lifestyle Instrument
por: Lazo, Oxana, et al.
Publicado: (2022)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
por: Baker, J., et al.
Publicado: (2020)

Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
por: Hu, Sicui, et al.
Publicado: (2021)

Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
por: Mancioppi, Valentina, et al.
Publicado: (2023)

Development and validation of an instrument for the evaluation of HIV care in Primary Health Care
por: Pinho, Clarissa Mourão, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2nnm21om95v8shd6h6vfk1nd6q